Major Topics:
1. Liver Progenitor Cells and iPS Cells
2. Hepatic Cell Fate Determination and Lineage Tracing
3. Liver Injuries, Repair and Treatment
4. Alcoholic and Non-Alcoholic Steatohepatitis
5. Hepatic Fibrogenesis and Therapeutics
6. Hepatocarcinogenesis and Novel Therapy
7. Immunotherapy for Liver Cancer
Keynote Speakers:
Lieping Chen, Yale University School of Medicine, USA
Inder Verma, The Salk Institute, USA
Abstract title: Cancer Stem Cells: Learning from Gliomas
Invited Speakers:
Fan Bai, Peking university, China
Abstract title: Intra-tumor genomic heterogeneity of Hepatocellular Carcinoma and combined Hepatocellular and Intrahepatic Cholangiocarcinoma
Rene Bernards, Netherlands Cancer Institute, THE NETHERLANDS
Abstract title: Finding new vulnerabilities of cancer cells for therapeutic benefit.
David Brenner, University of California, San Diego, USA
Abstract title: NADPH oxidase 1 promotes the development of hepatocellular carcinoma.
Xin Chen, University of California, San Francisco, USA
Abstract title: Combined CDK4/6 inhibitor and mTOR inhibitor for the treatment of cholangiocarcinoma
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: A New Preventive Therapy for Liver Cancer by Systematic Modulation of Innate and Adaptive Immunity
Ping Gao, University of Science & Technology of China, CHINA
Abstract title: Menin enhances c-Myc-mediated transcription to promote cancer progression
Markus Grompe, Oregon Health and Sciences University, USA
Abstract title: Injury responses in the liver
Tim Greten, National Cancer Institute, USA
Abstract title: The "immune" environment of HCC
Xin-Yuan Guan, The University of Hong Kong, CHINA
Abstract title: PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration activity and reprogramming glucose metabolism
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Involvement of the immune system in NASH and NASH-to-HCC transition
Lijian Hui, Shanghai Institute for Biological Sciences, CHINA
Abstract title: Cell identity conversion under epigenetic regulation
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed Cell Death in Inflammation and Liver Cancer
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Roles of hepatic non-parenchymal cells for liver fibrosis
David Moore, Baylor College of Medicine, USA
Abstract title: Regulation of liver energy balance by nutrient-sensing nuclear receptors
Takahiro Ochiya, National Cancer Center Research Institute, JAPAN
Abstract title: Conversion of mature hepatocytes into liver progenitor cells
Eli Pikarsky, The Hebrew University of Jerusalem, ISRAEL
Abstract title: Focal liver inflammation and HCC
Shuji Terai, Niigata University, JAPAN
Abstract title: Stem Cell therapy for liver cirrhosis -From autologous cell to allogeneic cell-
Fu-sheng Wang, Beijing 302 Hospital, CHINA
Xin Wei Wang, National Institute of Health, USA
Abstract title: Biological and clinical impacts of intertumor and intratumor heterogeneity in liver cancer
Yunfang Wang, Beijing Institute of Transfusion Medicine, CHINA
Abstract title: In vitro liver models for drug hepatotoxicity evaluation
Wei-Fen Xie, Changzheng Hospital, Second Military Medical University, CHINA
Abstract title: Chronic liver injuries induce the reprogramming of CK19+ biliary epithelial cells to hepatocytes
Shiou-Hwei Yeh, National Taiwan University College of Medicine, TAIWAN
Abstract title: Metabolism and Gender: Hepatic Androgen Receptor in NAFLD Pathogenesis
Victor Yu, National University of Singapore, SINGAPORE
Abstract title: MOAP-1 and Bid co-operate to execute Fas-mediated hepatocellular apoptosis but act paradoxically in regulating tumorigenesis in liver
Lars Zender, University Hospital Tuebingen, GERMANY
Abstract title: Functional Genetic Screening and Academic Drug Discovery to Improve Treatment of Patients with Liver Disease
Bin Zhou, Shanghai Institutes for Biological Sciences, CAS, CHINA
Abstract title: Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration
Jian Zhou, Zhongshan Hospital, Fudan Unviersity, CHINA
Abstract title: Liver Cancer: Diagnosis and Treatment in China
Jessica Zucman-Rossi, INSERM U674, FRANCE
We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.
Fellowship:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html
We look forward to seeing you at Suzhou in December, 2017.
Sponsored by:
